Will Chronic Pain Ever Go Away? The Odds, and What Moves Them

A school bus driver arrives after nine years of pain and six on an opioid. Nobody has told her that the disc on her film is the least interesting thing about her, or that much of what drives her pain can still be moved.

I am Dr. Gurpreet Singh Padda, MD, MBA, MHP, and the video above is the final chapter of The Pained Brain, written with Dr. KrisJay Fucanan, MD. Will chronic pain ever go away? For most people the honest answer is not all of it, and not this year. The share that does move is larger than most patients are told, and the variables that move it have names and measurements.

The odds, printed without softening

Among American adults with chronic pain in one year, 61.4% still had it the next and 10.4% were pain-free, a recovery rate above the 5.4% to 8.7% seen in four European cohorts. New chronic pain arrived at 52.4 per thousand person-years, several times the rate for diabetes. In Norway, 8% of people with moderate or severe chronic pain recovered within a year, and the authors put it bluntly: once pain has lasted several years, the prognosis becomes poor. In Scotland, 79% still had it four years later. Across eight waves of follow-up, only 11% improved gradually, while 31% crossed back and forth over the line, which is how most patients actually live it.

Two named conditions calibrate the picture. Among 1,555 people with fibromyalgia, 44% stopped meeting criteria at least once, 25% had at least moderate improvement in pain, and 38.6% got worse. Complex regional pain syndrome was symptom-free at a year in 5.4%. Those are the odds a patient gets when she is handed nothing else.

What the patient believes changes the odds

Among 406 people whose back pain had just turned chronic, 42% were pain-free at a year, and each point of perceived risk that the pain would last slowed recovery at a hazard of 0.91. In older adults followed five years, 38.5% recovered and 66.6% improved, and less optimistic beliefs at the start marked those who did not. Expectation predicts return to work where depression, job satisfaction and stress do not.

The hard end of it is hopelessness. Among 720 hospital inpatients, chronic pain carried 2.29 times the odds of a positive suicide screen, and hopelessness about one’s condition carried 5.69. Acceptance of pain broke the chain from severity to feeling like a burden to suicidal thinking, with the indirect effect falling from 2.50 at low acceptance to 0.08 at high. The scientists who named learned helplessness revised it after fifty years: passivity is the default response to pain nobody can control, and what gets learned is control. Hopelessness is not a mood. It is a prognostic factor, and it can start changing in a single visit.

Hope is delivered in the room

In 1987 a family doctor randomized 200 patients who had symptoms but no findings to a positive or a negative consultation. Two weeks later, 64% felt better after the positive visit against 39% after the negative one, while the treatment itself barely mattered, 53% against 50%. When nurses paired the same analgesic with better communication, pain fell 4.17 points instead of 2.29, and opioid use dropped.

The limit keeps the word honest: feeling reassured, by itself, did not reduce disability or healthcare use in acute back pain. Hope is a diagnosis, a mechanism, a plan with a dose, and a bridge across the worst of it.

Why policy alone cannot repair a terrain

The top-down case deserves its full strength. Comprehensive smoke-free laws brought coronary admissions down to 0.848 of their former level. New York counties that restricted trans fats saw heart attack and stroke admissions fall 6.2% more than counties that did not. Folic acid fortification prevents about 1,326 neural tube defects a year. No walking group did any of that.

Sugar is the fair test, because it is the terrain’s first input. Across 62 studies in more than 45 countries, beverage taxes passed 82% through to prices and cut sales 15%, yet consumption did not change significantly. Adult obesity in the United States climbed from 30.5% to 41.9%, and adults reporting pain rose from 49% to 54%, an additional 10.5 million people. The policies that worked removed one toxin from everyone. A terrain is a way of living, and it changes through the person living it, the argument behind treating metabolic disease at its dietary root.

Proven, and still undelivered

The Diabetes Prevention Program put 3,234 people with prediabetes through a coached lifestyle program and cut new diabetes by 58%, against 31% for metformin, one case prevented for every 6.9 people over three years. Scaled to a nation with more than 88 million adults at risk, the program enrolled 455,954 people in eight years. Medicare has paid for it since 2018, and 9,015 beneficiaries used it against about 5.2 million eligible. Only 35.5% of early participants reached the 5% weight-loss goal, and those who needed it most lost least, 3.3% among Black and American Indian participants against 5.1% among white ones. The system can prove a thing works. It still cannot hand it to a person at a kitchen table.

One kitchen, one roof

A person who changes changes the people she lives with. In the largest diabetes lifestyle trial, spouses who were never treated lost 2.2 kilograms against 0.2 among control spouses, 26% against 9% lost 5% of their weight, and fewer high-fat foods stayed in the house. In randomized couples, weight trajectories moved together at a correlation of 0.52. The older network studies are weaker, since the same statistics make a friend’s height contagious, so I rest on the trials.

Pain travels the same route. Children of a mother with chronic pain had 1.59 times the odds of pain complaints, and of a father 1.30. When women with a chronic pelvic pain condition were treated, their partners improved too, in both arms of the trial. One person’s recovery belongs to the household.

Most of the people who spread it are not physicians. When 592 low-income patients were paired with community health workers, their hospital days fell from 345 to 155. A diabetes prevention course run at a YMCA took off 6.0% of body weight against 2.0%. Peer support moved A1c by 0.20 and community health workers by 0.50 in the poorest patients. Small per person, and it adds up, because everyone who leads a walking group once joined one.

What a pain practice does with all of it

Teaching has a dose and a half-life. Diabetes education moves A1c by about 0.57 with ten contact hours as the threshold, and the early gain fades toward baseline by 52 weeks. Feedback holds what teaching starts: among smart-scale owners, a month without stepping on the scale cost an obese person 1.37 kilograms.

Terrain repair has known sizes. In the largest lifestyle trial, 11.5% of people with type 2 diabetes reached remission at a year against 2.0% with education alone, and at a normal body mass index, losing 6.5% of body weight put 70% of a small group into remission. The effect on pain is inferred from mechanism and from arthritis trials, where knee relief arrives at about 7% of weight lost. Procedures remain a bridge that buys function now, never the destination, the point made in the chapter on what fee-for-service builds.

So the physician’s first act is to refuse, out loud, to consign anyone to the average, then to hand over the markers: A1c, fasting insulin, kidney function, a weight target as a percentage, and your own expectation of recovery written where you both can see it. The woman in the waiting room now leads a Tuesday walking group from a church parking lot. Her story reflects practice-reported figures from our own population, not trial outcomes, and individual results vary. How the five inputs interact is in the chapter on mind and metabolism, diabetes remission and pain are covered in what remission does to chronic pain, and the Chapter 22 supplement lists every study named here with what it cannot show.

Frequently asked questions

Will chronic pain ever go away?

For most people, not entirely and not quickly. In national data 61.4% of adults with chronic pain still had it a year later and 10.4% were pain-free, and the odds worsen once pain has lasted several years. What moves more readily is interference, spread and function, which respond to the terrain and to what a patient believes about recovery. How many chances you actually get at pain management.

Does losing weight help chronic pain?

Measurably, and the threshold matters. In knee osteoarthritis, meaningful relief is expected at about 7% of body weight lost. On the metabolic side, 11.5% of people in the largest lifestyle trial reached diabetes remission at a year against 2.0% with education. Diet alone can drive remission in type 2 diabetes.

Does my chronic pain affect my family?

Yes, in both directions. Children of a mother with chronic pain carried 1.59 times the odds of pain complaints, and caregivers of children in pain lost 38% of their work productivity. The encouraging half is that recovery travels the same route, and partners of treated patients improved without being treated themselves. Five ways to support the person caring for you.

Is another procedure worth it?

That depends on what the weeks after it are for. In one series, 30.5% of patients who had stopped working returned to work after a stimulator implant, and being out of work longer than three years beforehand sharply cut those odds. A procedure that buys function early, so the terrain work can happen, is medicine. Why each injection can buy less time than the last.

What should I bring to a first appointment?

Your medication list, your procedure history and any recent labs, especially an A1c, a fasting insulin and kidney function. Write down when the pain began, what has changed since, and what you believe your chances of recovery are, because that expectation is a variable in your own chart. What actually happens at a first interventional pain appointment.

Sources

1. Nahin, R. L., Feinberg, T., Kapos, F. P., & Terman, G. W. (2023). Estimated Rates of Incident and Persistent Chronic Pain Among US Adults, 2019-2020. JAMA Network Open, 6(5), e2313563. https://doi.org/10.1001/jamanetworkopen.2023.13563
2. Landmark, T., Dale, O., Romundstad, P., Woodhouse, A., Kaasa, S., & Borchgrevink, P. C. (2018). Development and course of chronic pain over 4 years in the general population: The HUNT pain study. European Journal of Pain, 22(9), 1606–1616. https://doi.org/10.1002/ejp.1243
3. Costa, L. da C. M., Maher, C. G., McAuley, J. H., Hancock, M. J., Herbert, R. D., Refshauge, K. M., & Henschke, N. (2009). Prognosis for patients with chronic low back pain: inception cohort study. BMJ, 339, b3829. https://doi.org/10.1136/bmj.b3829
4. Ryan, P. C., Lowry, N. J., Boudreaux, E., Snyder, D. J., Claassen, C. A., Harrington, C. J., Jobes, D. A., Bridge, J. A., Pao, M., & Horowitz, L. M. (2023). Chronic Pain, Hopelessness, and Suicide Risk Among Adult Medical Inpatients. Journal of the Academy of Consultation-Liaison Psychiatry, 65(2), 126–135. https://doi.org/10.1016/j.jaclp.2023.11.686
5. Maier, S. F., & Seligman, M. E. P. (2016). Learned helplessness at fifty: Insights from neuroscience. Psychological Review, 123(4), 349–367. https://doi.org/10.1037/rev0000033
6. Thomas, K. B. (1987). General practice consultations: is there any point in being positive? British Medical Journal (Clinical Research Ed.), 294(6581), 1200–1202. https://doi.org/10.1136/bmj.294.6581.1200
7. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., Nathan, D. M., & Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346(6), 393–403. https://doi.org/10.1056/NEJMoa012512
8. Gorin, A. A., Wing, R. R., Fava, J. L., Jakicic, J. M., Jeffery, R., West, D. S., Brelje, K., & Dilillo, V. G. (2008). Weight loss treatment influences untreated spouses and the home environment: evidence of a ripple effect. Int J Obes (Lond), 32(11), 1678–84. https://doi.org/10.1038/ijo.2008.150
9. Kangovi, S., Mitra, N., Norton, L., Harte, R., Zhao, X., Carter, T., Grande, D., & Long, J. A. (2018). Effect of Community Health Worker Support on Clinical Outcomes of Low-Income Patients Across Primary Care Facilities: A Randomized Clinical Trial. JAMA Intern Med, 178(12), 1635–1643. https://doi.org/10.1001/jamainternmed.2018.4630
10. Shahid, A., Thirumaran, A. J., Christensen, R., Venkatesha, V., Henriksen, M., Bowden, J. L., & Hunter, D. J. (2024). Comparison of weight loss interventions in overweight and obese adults with knee osteoarthritis: A systematic review and network meta-analysis of randomized trials. Osteoarthritis and Cartilage, 33(4), 518–529. https://doi.org/10.1016/j.joca.2024.08.012

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 22 of The Pained Brain by Dr. Padda and Dr. KrisJay Fucanan, MD. Last reviewed September 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP